Mirum Pharmaceuticals, Inc. MIRM Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$798.84M-933% | -$23.36M+73.4% | -$41.42M+58.5% | -$58.56M+46.4% | -$77.34M+51.2% | ||
| $25.07M+4.4% | $24.24M+2.6% | $24.23M+5.0% | $24.22M+23.1% | $24.02M+58.5% | ||
| $91.82M+73.9% | $71.42M+47.4% | $65.65M+46.2% | $59.43M+43.6% | $52.8M+39.3% | ||
| -$170.98M— | $55.83M— | —— | —— | —— | ||
| $1.58M+54.5% | $954K-3.9% | $374K— | $368K— | $1.02M— | ||
| -$20.4M+80.9% | -$24.96M+72.5% | -$24.96M+73.1% | -$40.77M+84.2% | -$106.89M+20.4% | ||
| $303.86M+1,230% | $40.14M+127% | $36.48M+158% | $24.25M-88.8% | $22.85M-93.0% | ||
| $114.39M+226% | $75.24M+219% | $59.11M— | -$4.89M— | -$90.6M— | ||
| -$172.55M— | $54.87M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Mirum Pharmaceuticals, Inc. generate?
- Mirum Pharmaceuticals, Inc. (MIRM) generated -$171.0M in operating cash flow over the trailing twelve months.
- What is Mirum Pharmaceuticals, Inc.'s free cash flow?
- After $1.6M of capital expenditures, Mirum Pharmaceuticals, Inc.'s free cash flow was -$172.6M over the trailing twelve months, down 45270.7% year over year.
- Where does Mirum Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Mirum Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
